查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496762

臨床試驗用品市場：按階段、類型、產品、治療領域和最終用戶分類 - 全球預測 2024-2030

Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), Type (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年臨床試驗用品市場規模為33.5億美元，2024年達36.4億美元，預計2030年將達到59.2億美元，複合年成長率為8.43%。

研究是臨床研究的一個基本而複雜的要素，最終有助於為成功的治療方法突破和患者治療途徑的突破性改進鋪平道路。這些用品支持從臨床前測試到上市後監測的各個研究階段，促進臨床試驗的無縫管理和進行。全球感染疾病和慢性病的流行以及隨之而來的製藥和生物製藥行業的臨床試驗和研發費用的增加將刺激市場成長。與臨床試驗供應相關的高成本、嚴格的供應法規以及跨境物流挑戰限制了市場成長。專注於藥物開發和轉向以患者為中心的臨床試驗可以改善臨床試驗患者招募、試驗入組和參與者保留率。此外，不同主題_KEYWORD的持續進展預計將為製藥和生物製藥公司開闢新的研究途徑。

主要市場統計
基準年[2023] 33.5億美元
預測年份 [2024] 36.4億美元
預測年份 [2030] 59.2億美元
複合年成長率（%） 8.43%

區域洞察

以美國和加拿大為中心的美洲地區慢性病診斷率高，醫療基礎設施強大，對臨床試驗供應高度依賴。去年註冊的主要專利與最佳化供應鏈模型和採用先進分析來匹配測試供應與需求有關。由於醫療保健的取得和支出存在差異，歐盟 (EU)、中東和非洲的需求多種多樣。在歐洲，受研發密集投資和老年人口快速成長的推動，對 Theme_KEYWORD 的需求穩定。相較之下，中東和非洲國家是新興市場，研究活動活躍，但資金和基礎設施有限。包括中國、日本和印度在內的亞太地區由於醫療基礎設施的大量投資，疾病發生率很高。蓬勃發展的製藥業正在推動這些地區的臨床試驗用品市場，其需求是由成本效益而不是速度驅動的。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在臨床試驗用品市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對臨床試驗用品市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在臨床試驗用品市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地感染疾病和慢性病的盛行率正在增加。
      • 醫藥及生技製藥產業研發費用增加
    • 抑制因素
      • 臨床試驗耗材成本高
    • 機會
      • 重視藥物開發並轉向以病人為中心的臨床試驗
      • 多樣化臨床試驗用品的持續進步
    • 任務
      • 臨床試驗用品嚴格監管
  • 市場區隔分析
    • 階段：為了做出臨床試驗的最佳決策，對臨床試驗用品的需求會階段性增加。
    • 類型：慢性病治療方法突破，生物藥需求快速成長
    • 產品：輔助藥物是臨床試驗的關鍵組成部分，因為它們對於確保研究的安全性和整體效率至關重要。
    • 治療領域：全球感染疾病負擔增加，臨床試驗用品需求增加
    • 最終用戶：研發活動外包的增加增加了 CRO 中臨床試驗用品的使用。
  • 市場趨勢分析
    • 各大製藥公司都專注於增加臨床試驗的數量，增加了美洲對臨床試驗用品的需求。
    • 擴大政府努力，加強亞太地區的臨床試驗能力，並制定配套法規和標準。
    • 歐洲、中東和非洲地區臨床試驗的增加以及強大而先進的製藥業
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章 臨床試驗用品市場分階段狀況

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第7章 臨床試驗用品市場：依類型

  • 生物製藥
  • 醫療設備
  • 小分子

第8章臨床試驗用品市場：依產品

  • 輔助藥物
  • 互動式響應技術（IRT）解決方案
  • 實驗室用品
  • 醫療設備和診斷
  • 藥局用品
  • 調查數據
  • 安全裝置

第9章依治療領域分類的臨床試驗用品市場

  • 心臟病學
  • 遺傳疾病
  • 免疫學
  • 感染疾病
  • 代謝紊亂
  • 神經病學
  • 腫瘤學

第10章臨床試驗用品市場：依最終使用者分類

  • 合約調查機構
  • 製藥和生物技術公司

第11章 北美和南美臨床試驗用品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太臨床試驗用品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東、非洲臨床試驗用品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 訊號：英國臨床研究提供商 Ergomed 將以 8.88 億美元收購
    • 賽默飛世爾科技推出全新智慧冰箱系列
    • Loftware 和 Tenthpin 合作開發臨床供應標籤
    • Sitero 收購 Clario 的 eClinical 技術套件以增強臨床試驗執行
    • Replimune 與 Insight 簽署臨床試驗合作及供應協議，評估 RP1 和 INCB99280 在皮膚鱗狀細胞癌患者的應用
    • BD 推出新型機器人系統以實現臨床流式細胞技術自動化
    • Lonza 收購 Synafix 以加強抗體藥物複合體產品
    • IDEAYA 擴大了與輝瑞的臨床試驗合作和供應協議，以支持一項評估 Darovasertib 和 Crizotinib 組合用於轉移性葡萄膜黑色素瘤一線治療的註冊試驗。
    • Plus Therapeutics 擴大與 Piramal Pharma Solutions 的合作關係，以滿足正在進行和計劃的臨床試驗中對臨床實驗藥物日益成長的需求
    • 西門子 Healthineers 在索茲開設實驗設備研發中心
    • Experic完成1,400萬美元B輪資金籌措
    • Medline 額外投資 5 億美元用於醫療用品庫存，以增強產品可用性

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-E0619F076721

[199 Pages Report] The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030.

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.64 billion
Forecast Year [2030] USD 5.92 billion
CAGR (%) 8.43%

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Clinical Trial Supplies Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of infectious and chronic diseases worldwide
      • Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • Market Restraints
      • High cost of clinical trial supplies
    • Market Opportunities
      • Emphasis on drug development and shift towards patient-centric clinical trials
      • Ongoing advancements in a diverse range of clinical trial supplies
    • Market Challenges
      • Stringent regulations for clinical trial supplies
  • Market Segmentation Analysis
    • Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Trial Supplies Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal

Permira, a UK private equity firm, agreed to acquire Ergomed for USD 888.1 million. Ergomed is a clinical trial development and management services provider, catering to clients across more than 100 countries. This strategic acquisition can expand Permira's already impressive portfolio of medical companies, including Neurapharm and Cambrex. [Published On: 2023-09-04]

Thermo Fisher Scientific Launches New Smart Refrigerator Series

Thermo Fisher Scientific introduced the Thermo Scientific TM TSG series refrigerators, specifically engineered to cater to the stringent demands of diverse industries. These cutting-edge refrigerators leverage advanced technology to ensure accurate temperature control, effectively preserving the integrity of vaccines and pharmaceuticals. By minimizing temperature fluctuations, these refrigerators effectively mitigate the risks associated with such variations, safeguarding medical products' potency and efficacy. [Published On: 2023-08-16]

Loftware and Tenthpin Collaborate on Clinical Supply Labeling

Loftware and Tenthpin collaborated to launch a software called Loftware Prisym 360, which is specifically designed for clinical supply labeling. The main objective of this partnership is to address the growing challenges faced by clinical trial supply teams within the pharmaceutical industry. This agreement enables both Loftware and Tenthpin to actively promote, educate, and implement a comprehensive content and labeling solution for their clinical customers. [Published On: 2023-08-02]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Trial Supplies Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Type
    • Biologic Drugs
    • Medical Devices
    • Small-Molecules
  • Product
    • Auxiliary Medicinal Products
    • Interactive Response Technology (IRT) solutions
    • Lab Supplies
      • Centrifuges
      • Microscopes
      • Pipettes
      • Reagents
    • Medical Devices & Diagnostics
    • Pharmacy Supplies
      • Biohazard Bags
      • Compounding Aseptic Isolators
      • Sterilization Equipment
    • Research Materials
    • Safety Equipment
  • Therapeutic Area
    • Cardiology
    • Genetic Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Oncology
  • End User
    • Contract Research Organisations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical trial supplies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
      • 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for clinical trial supplies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • 5.3. Market Trend Analysis
    • 5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
    • 5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
    • 5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Clinical Trial Supplies Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

  • 8.1. Introduction
  • 8.2. Auxiliary Medicinal Products
  • 8.3. Interactive Response Technology (IRT) solutions
  • 8.4. Lab Supplies
  • 8.5. Medical Devices & Diagnostics
  • 8.6. Pharmacy Supplies
  • 8.7. Research Materials
  • 8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Genetic Diseases
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Metabolic Disorders
  • 9.7. Neurology
  • 9.8. Oncology

10. Clinical Trial Supplies Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
    • 14.3.2. Thermo Fisher Scientific Launches New Smart Refrigerator Series
    • 14.3.3. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
    • 14.3.4. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
    • 14.3.5. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
    • 14.3.6. BD Launches New Robotic System to Automate Clinical Flow Cytometry
    • 14.3.7. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.8. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
    • 14.3.9. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
    • 14.3.10. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords
    • 14.3.11. Experic Closes USD 14 Million Series B Financing
    • 14.3.12. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 95. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 96. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 119. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 120. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 121. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 122. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 132. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 133. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 134. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 135. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 136. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 137. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 146. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 147. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 148. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 149. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 150. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 151. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 161. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 162. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 163. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 164. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 165. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 166. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 167. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 168. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 186. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 187. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 192. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 193. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 194. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 196. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 200. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 201. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 206. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 207. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 208. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 209. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 210. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 211. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 214. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 215. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 220. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 221. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 222. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 223. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 224. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 225. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 228. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 229. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 234. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 235. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 236. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 237. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 238. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 239. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 242. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 243. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 248. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 249. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 250. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 251. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 252. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 253. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 256. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 257. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 262. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 263. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 264. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 265. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 266. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 267. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 270. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 276. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 277. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 278. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 279. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 280. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 281. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 284. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 285. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 290. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 291. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 292. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 293. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 294. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 295. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 298. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 304. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 305. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 306. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 307. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 308. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 309. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 310. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 311. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 312. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 313. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 318. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 319. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 320. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 321. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 322. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 323. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 326. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 327. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 330. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 331. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 332. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 333. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 334. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 335. THAIL